Invention Grant
- Patent Title: Diacylglycerol acyltransferase 2 inhibitors
- Patent Title (中): 二酰基甘油酰基转移酶2抑制剂
-
Application No.: US14643210Application Date: 2015-03-10
-
Publication No.: US09440949B2Publication Date: 2016-09-13
- Inventor: Shawn Cabral , Kentaro Futatsugi , David Hepworth , Kim Huard , Daniel Wei-Shung Kung , Suvi Tuula Marjukka Orr , Kun Song
- Applicant: PFIZER INC.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Lisa A. Samuels
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/606 ; A61K31/506 ; A61K31/4545 ; A61K45/06 ; C07D401/04 ; C07D487/04 ; C07D413/14 ; C07D491/08 ; C07D401/14 ; C07D487/02
Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.
Public/Granted literature
- US20150259323A1 DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS Public/Granted day:2015-09-17
Information query
IPC分类:
